News
Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 supera ...
Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 superagonist delivery to metastatic tumor sites and reduced immune cle ...
Rising prices have parents tightening their budgets. Here’s how to shop smart, spend less and still get the essentials.
Continental Tires EMEA has merged its internal and external communications teams to create an integrated structure for its tire replacement busin ...
Explore compelling crypto ad regulation data, discover how new rules curb scams, influence, and shape marketing compliance ...
Detailed price information for Obsidian Energy Ltd (OBE-T) from The Globe and Mail including charting and trades.
Net loss per share (GAAP) was $0.62, but remained negative as the company continues to invest heavily in research and development. The pivotal Phase 2 trial for Danon disease was placed on clinical ...
A string of US armory break-ins, kept quiet by authorities for months, points to a growing security crisis—and signs of an ...
Phase 2 topline data from Avail trial expected in Q3 2025. Topline results from the Phase 2 Avail trial of canvuparatide, a potential long-acting, once-weekly parathyroid hormone (PTH) peptide prodrug ...
Revenue of $5.5 billion increased 10.4% as reported, 8.5% adjusted FXN and 3.0% organicGAAP and adjusted diluted EPS grew to $2.00 and $3.68, ...
Almirall and Absci have expanded their AI-based drug discovery collaboration by selecting a second dermatological target, following the initial s ...
The REA Group Ltd (ASX: REA) share price reacted very positively to the FY25 result. The broker UBS thinks there are more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results